Your browser does not support JavaScript or it may be disabled!

NewsApp (Free)

Read news as it happens
Download NewsApp
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News Home   |   Images Home
 rediff News App

About 126 results for "centrum broking"

Centrum Broking maintains BUY on RIL

Related to : Reliance Industries Ltd Reliance Industries Ltd BSE 18 Apr 13 | 09:07 AM 774.50 0.4 (0.05%) NSE 17 Apr 13 | 12:00 AM 773.70 0 (0%) Reliance Industries performance in Q4 was largely in line in terms of profitability but operationally ... Smart Investor, 1 month ago
Centrum Broking recommends Balrampur Chini Smart Investor, 1 month ago
See all (4) images for "centrum broking"
Moneycontrol.com, 1 month ago
Moneycontrol.com, 1 month ago
Moneycontrol.com, 1 month ago
Moneycontrol.com, 4 months ago
See all (4) images for "centrum broking"

Centrum Broking maintains neutral rating on Ashok Leyland

Ashok Leyland's (ALL) 4QFY13 overall results were significantly lower than our expectations with EBITDA margin at 5.3% vs. est. 8.1%. Revenues stood at Rs.37bn compared to our estimate of Rs.35.6bn, higher by 4.8% largely driven by better than ...
 Smart Investor1 week ago
Money Control

Buy ICICI Bank, Maruti Suzuki, Merck: Centrum Broking

Related to : Maruti Suzuki India Ltd,Merck Ltd,ICICI Bank Ltd Maruti Suzuki India Ltd BSE 26 Apr 13 | 12:00 AM 1673.45 83.7 (5.27%) NSE 26 Apr 13 | 12:00 AM 1673.15 82.2 (5.17%) ICICI Bank Buy Target Price: Rs1,400 CMP: Rs1,145 Upside: 22.3% ...
 Smart Investor3 weeks ago Ajay Shethiya neutral on MM  Money Control1 month ago Ajay Shethiya positive on Tata Motors  Money Control1 month ago Buy Maruti Suzuki: Shethiya  Money Control1 month ago
Indian Express

Centrum maintains 'sell' rating on Ranbaxy, target Rs 400

Related to : Ranbaxy Laboratories Ltd Ranbaxy Laboratories Ltd BSE 13 May 13 | 09:37 AM 447.00 -1.95 (-0.43%) NSE 13 May 13 | 09:30 AM 447.25 -1.7 (-0.38%) Ranbaxy Labs results for the first quarter (Jan-Mar) of 2013 were below our expectations.
 Smart Investor1 week ago Ranbaxy's rocky road ahead after $500M settlement  FiercePharma6 days ago Ranbaxy may take a $1-billion hit in US  Economic Times1 week ago Ranbaxy Laboratories shares pull off sensational U-turn post-$500 mn penalty  Indian Express1 week ago
[x]  

Expect a correction in near term, say fund managers

Markets posted their third-straight weekly gains on hopes of global growth recovery after the central bank's monetary policy easing. Risk appetite improved after the US Federal Reserve and European Central Bank kept the monetary policy loose to ...
 Smart Investor2 weeks ago
Money Control

SC verdict will not give major relief to Sesa Goa: Centrum

Supreme Courts decision of allowing mining in Category B mines in Karnataka will give little relief to Sesa Goa because most of its operations are in Goa, which is still shut and they have little capacity in Karnataka, Abhisar Jain of Centrum Broking said.
 Money Control1 month ago

Centrum Capital eyes fund raising options

Everstone-backed Centrum Capital is exploring options to raise capital, possibly through additional private equity (PE) investment. The matter is to be discussed at a board meeting on April 4, according to an exchange notification. Everstone ...
 Smart Investor1 month ago Centrum Capital explores fundraising options  Smart Investor2 months ago
Outlookbusiness.com

Jaipur Leather Fest

What are these guys staring at? Why has work stopped? Suresh Kumar Poddar asks as a bunch of curious workers gather to watch him gingerly position himself amidst some 30-odd, five foot-high rolls of synthetic leather for a photo shoot. The shopfloor ...
 Outlookbusiness.com2 days ago
Moneycontrol.com

Lupin falls 5% on Mylan drug launch, downgrade

NEW DELHI: Shares in Lupin Ltd slump nearly 5 per cent following the launch of rival Mylan Inc's generic version of the cholesterol-lowering Tricor tablets. Earlier in the day, Credit Suisse downgraded Lupin from 'outperform' to 'neutral' rating as ...
 Economic Times2 days ago Lupin down 4% on likely decline in market share of Tricor  Moneycontrol.com2 days ago Lupin falls; Mylan launches cholesterol drug  Yahoo! Finance2 days ago
[x]  

Investors make gains amid high volatility

Benchmark share indices gained for the fifth straight week, amid high volatility, led by rate-sensitive shares, after a sharp decline in wholesale inflation numbers in April rekindled hopes of a steeper rate cut by the central bank. Three of the six ...
 Smart Investor3 days ago Software, banking shares raise sentiments marginally  Smart Investor1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts
WidgetGet Realtime news on your homepage & get your members hooked.Add Realtime Widget
 rediff News App

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
    
Widget
Get Realtime News on your webpage & get your members hooked!
 
More     Less